U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07548164) titled 'Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer' on April 17.
Brief Summary: In this study we will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for people with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
Study Start Date: April 16
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Intervention:
DEVICE: NanoKnife System
The NanoKnife System is the device that is used for Irreversible Electroporation/IRE. The Na...